Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis
BackgroundThis study aimed to compare the clinical outcomes of patients with hepatocellular carcinoma (HCC) and macroscopic tumor thrombosis who were treated with lenvatinib with or without combined liver-directed radiotherapy (LRT).MethodsFrom the institutional registry, we enrolled 82 patients dia...
Main Authors: | Jeong Il Yu, Wonseok Kang, Gyu Sang Yoo, Myung Ji Goh, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Jung Yong Hong, Ho Yeong Lim, Boram Park, Hee Chul Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.888755/full |
Similar Items
-
Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
by: Myung Ji Goh, et al.
Published: (2023-02-01) -
Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
by: Byeong Geun Song, et al.
Published: (2023-09-01) -
Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer
by: Clarissa Lam, et al.
Published: (2023-10-01) -
Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation
by: Kyunghye Bang, et al.
Published: (2023-02-01) -
Thrombotic microangiopathy associated with lenvatinib therapy
by: Macarena Contreras Angulo, et al.
Published: (2023-04-01)